Go to:
Logótipo
Você está em: Start > Publications > View > Prioritizing pharmaceutically active compounds (PhACs) based on occurrence-persistency-mobility-toxicity (OPMT) criteria: an application to the Brazilian scenario
Publication

Prioritizing pharmaceutically active compounds (PhACs) based on occurrence-persistency-mobility-toxicity (OPMT) criteria: an application to the Brazilian scenario

Title
Prioritizing pharmaceutically active compounds (PhACs) based on occurrence-persistency-mobility-toxicity (OPMT) criteria: an application to the Brazilian scenario
Type
Article in International Scientific Journal
Year
2023
Authors
Roveri, V
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Guimaraes, LL
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Correia, AT
(Author)
ICBAS
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 34
Pages: 1023-1039
ISSN: 1062-936X
Publisher: Taylor & Francis
Indexing
Publicação em ISI Web of Knowledge ISI Web of Knowledge - 0 Citations
Publicação em Scopus Scopus - 0 Citations
Other information
Authenticus ID: P-00Z-FV1
Abstract (EN): A study of Quantitative Structure Activity Relationship (QSAR) was performed to assess the possible adverse effects of 25 pharmaceuticals commonly found in the Brazilian water compartments and to establish a ranking of environmental concern. The occurrence (O), the persistence (P), the mobility (M), and the toxicity (T) of these compounds in the Brazilian drinking water reservoirs were evaluated. Moreover, to verify the predicted OPMT dataset outcomes, a quality index (QI) was also developed and applied. The main results showed that: (i) after in silico predictions through VEGA QSAR, 19 from 25 pharmaceuticals consumed in Brazil were classified as persistent; (ii) moreover, after in silico predictions through OPERA QSAR, 15 among those 19 compounds considered persistent, were also classified as mobile or very mobile. On the other hand, the results of toxicity indicate that only 9 pharmaceuticals were classified with the highest toxicity level. Ultimately, the QI of 7 from 25 pharmaceuticals were categorized as 'optimal'; 15 pharmaceuticals were categorized as 'good'; and only 3 pharmaceuticals were categorized as 'regular'. Therefore, based on the QI criteria used, it is possible to assume that this OPMT prediction dataset had a good reliability. Efforts to reduce emissions of OPMT-pharmaceuticals in Brazilian drinking water reservoirs are encouraged.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 17
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Occurrence of human adenoviruses in a beach area of Guaruja, Sao Paulo, Brazil (2020)
Article in International Scientific Journal
Roveri, V; Guimaraes, LL; Correia, AT; Demoliner, M; Spilki, FR

See all (9)

Of the same journal

Topological structural alerts modulations of mammalian cell mutagenicity for halogenated derivatives (2013)
Article in International Scientific Journal
Perez Garrido, A; Giron Rodriguez, F; Helguera, AM; Borges, F; Combes, RD
Topological structural alerts modulations of mammalian cell mutagenicity for halogenated derivatives (2014)
Article in International Scientific Journal
Perez Garrido, A; Giron Rodriguez, F; Morales Helguera, AM; Fernanda Borges; Combes, RD
Comparative study to predict toxic modes of action of phenols from molecular structures (2013)
Article in International Scientific Journal
Brito Sanchez, Y; Castillo Garit, JA; Le Thi Thu, H; Gonzalez Madariaga, Y; Torrens, F; Marrero Ponce, Y; Rodriguez Borges, JE
Recommend this page Top
Copyright 1996-2026 © Faculdade de Farmácia da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2026-02-26 at 08:04:43 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book